https://www.selleckchem.com/products/qx77.html
61), psychiatric symptomatology (RR=1.44) and (mild) challenging behaviours (RR=4.58). Further efforts are needed to provide adequate mental health care, specifically to improve PM treatment regarding amount, indication and the consideration of non-psychopharmacological treatment options. Further efforts are needed to provide adequate mental health care, specifically to improve PM treatment regarding amount, indication and the consideration of non-psychopharmacological treatment options. There is lack of evidence and research understanding